Inovio Pharmaceuticals
INO
INO
103 hedge funds and large institutions have $20.7M invested in Inovio Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
-4
Holders Change %
-3.74%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
22
Reduced
30
Closed
28
Calls
$1.4M
Puts
$94K
Net Calls
+$1.3M
Net Calls Change
+$904K
Top Buyers
| 1 |
Millennium Management
New York
|
+$706K |
| 2 |
Renaissance Technologies
New York
|
+$574K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$349K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$344K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$332K |
Top Sellers
| 1 |
BlackRock
New York
|
-$3.62M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.32M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$845K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$833K |
| 5 |
State Street
Boston,
Massachusetts
|
-$795K |
